Cosmetic cross-reference

L-Citrulline

CAS 372-75-8

L-Citrulline (CAS 372-75-8) is a Phase 3 pharmaceutical compound with 3 bioactivity targets and 3 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
3
SOURCE DrugCentral
Adverse signals
3
SOURCE IUPHAR/BPS
PubMed IDs
1
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
L-Citrulline
CAS Number
372-75-8
UNII
29VT07BGDA
InChIKey
RHGKLRLOHDJJDR-BYPYZUCNSA-N
ChEMBL ID
CHEMBL444814
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
Synonyms and normalized names
CITRULLINE
natural product
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 3
Late-stage clinical development phase from the compound identifier source.
ChEMBL CHEMBL444814 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE EMBL-EBI ChEMBL 3 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- AC50 30000 nM 31 -
- IC50 19976.309999999998 nM 1 -
- Kd 68000 nM 1 -
SOURCE DrugCentral 3 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Hyperammonaemic crisis 16 155.593 10073509
Hyperammonaemia 12 56.735 10020575
Ammonia increased 11 54.65 10001946

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE IUPHAR/BPS 1 interaction

IUPHAR Ligand-Target Data

Curated ligand-target interaction rows with action, affinity, and literature identifiers.

TargetAction AffinityPubMed
GPRC6
GPRC6A
Full agonist 3.6 pEC50 15576628
SOURCE NLM RxNorm 2 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
CITRULLINE 2567 SU MTHSPL
citrulline 2567 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is L-Citrulline used for in pharmaceutical contexts?

L-Citrulline (CAS 372-75-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for L-Citrulline?

L-Citrulline has 3 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Hyperammonaemic crisis, Hyperammonaemia, Ammonia increased. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is L-Citrulline also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for CITRULLINE with EU status "permitted".

What clinical phase is L-Citrulline in?

L-Citrulline is rendered with ChEMBL max phase 3.